vimarsana.com
Home
Live Updates
IL-23, IL-17 Inhibitors Associated with Lower Risk of Severa
IL-23, IL-17 Inhibitors Associated with Lower Risk of Severa
IL-23, IL-17 Inhibitors Associated with Lower Risk of Several Malignancies Compared to TNFi
This new data should be taken into account before biologics prescriptions are made for patients with conditions such as psoriasis.
Related Keywords
Italy ,
Israel ,
Spain ,
Ireland ,
Germany ,
Republic Of Ireland ,
Researchgate Khalaf Kridin ,
Khalaf Kridin ,
Dermatol Venereol ,
Global Collaborative Network ,
Institute Of Experimental Dermatology ,
Experimental Dermatology ,
Eur Acad Dermatol ,
Accepted Author ,
Cancer ,
Malignancy ,
Il 17 ,
Il 23 ,
Psoriasis ,